Protalix BioTherapeutics (PLX) Reports Q4 EPS of $0.02
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.37 +0.42%
Revenue Growth %: -49.8%
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
BWMX, BPRN, FWRD, More
Revenue Growth %: -49.8%
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
BWMX, BPRN, FWRD, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q4 EPS of $0.02, versus ($0.04) reported last year. Revenue for the quarter came in at $3.8 million, versus $1.8 million reported last year.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- STMicroelectronics N.V. (STM) Tops Q2 EPS by 6c; offers guidance
- Es Bancshares, Inc. (ESBS) Tops Q2 EPS by 13c
- Peoples Financial Corp/ms (PFBK) Tops Q2 EPS by 19c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
